feed,title,long_url,short_url
Barron's,Biogen Stock Gains Before Anticipated FDA Decision,https://www.barrons.com/articles/biogen-stock-fda-alzheimers-aducanumab-51623066116?mod=RTA,https://j.mp/2SZxPGF
